New treatment option for Macular Hole Surgery
Official title Autologous Tenon's Capsule Graft for Refractory Macular Holes
ClinicalTrials.gov ID: NCT07318961
What this study is testing
- What it's testing
- This prospective interventional study evaluates the anatomical and functional outcomes of autologous Tenon's capsule grafting in patients with refractory full-thickness macular holes. Eligible patients include those with chronic large macular holes (\>400 µm) or persistent holes following prior pars plana vitrectomy with internal limiting membrane peeling and gas tamponade.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- Refractory full-thickness macular hole defined as:
- Chronic macular hole \>400 µm, or
- Persistent macular hole following prior vitrectomy with ILM peeling and gas tamponade
- Clear ocular media and adequate fixation for OCT imaging
You likely can't join if
- Active ocular infection or inflammation
- Advanced glaucoma or optic neuropathy
- History of intraocular tumors
- Severe proliferative vitreoretinopathy
- Significant systemic diseases likely to affect visual recovery
See the full eligibility criteria
- Age 18 years or older
- Refractory full-thickness macular hole defined as:
- Chronic macular hole \>400 µm, or
- Persistent macular hole following prior vitrectomy with ILM peeling and gas tamponade
- Clear ocular media and adequate fixation for OCT imaging
- Ability to provide informed consent
- Active ocular infection or inflammation
- Advanced glaucoma or optic neuropathy
- History of intraocular tumors
- Severe proliferative vitreoretinopathy
- Significant systemic diseases likely to affect visual recovery
The study team makes the final eligibility decision.
Where it's taking place
- Banhā, Benha, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Banhā, Benha, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.